Table 1.
CSF biomarker values for the 11 AD patients tested
| Patient | Age | Sex | CSF t-tau (pg/ml) | CSF p-tau (pg/ml) | CSF Aβ42 (pg/ml) | ATI |
|---|---|---|---|---|---|---|
| UT-1 | 69 | F | 993.4 | 99 | 303.15 | 0.21 |
| UT-2 | 76 | M | 398 | 75.95 | 395.25 | 0.56 |
| UT-3 | 69 | F | 1768.8 | 193.25 | 226.9 | 0.10 |
| UT-4 | 71 | M | 869.85 | 128.9 | 296.1 | 0.23 |
| UT-5 | 68 | M | NA | NA | NA | NA |
| UT-6 | 51 | M | NA | NA | NA | NA |
| UT-7 | 63 | M | 1137.45 | 132.9 | 373.55 | 0.24 |
| UT-8 | 63 | M | 1098 | 128.65 | 233.2 | 0.15 |
| UT-9 | 76 | F | 430.3 | 73.6 | 279.85 | 0.37 |
| UT-10 | 91 | M | 538.3 | 85.4 | 446.4 | 0.51 |
| UT-11 | 74 | F | 562.65 | 98.25 | 255.85 | 0.28 |
| NC | 64 | F | 134.95 | 32.15 | 561.45 | 1.41 |
CSF is considered consistent with AD if p-tau > 68 pg/ml and ATI < 0.8. ATI is defined as Aβ42/(240 + 1.18*t-tau). NC is normal control